We are excited to announce that Softhale N.V. has changed its name to invoX Belgium N.V. We are now a part of invoX Pharma, a research-driven global biopharmaceutical company that acquired Softhale in March 2021. The team will be known as the Respiratory Innovation Centre and we look forward to continuing our innovative work in respiratory medicine and the exciting development of the Softhaler®. For more information about us, visit www.invoxpharma.com
